338
Participants
Start Date
August 31, 2007
Primary Completion Date
June 30, 2018
Study Completion Date
June 30, 2018
Lifestyle intervention
Women randomized to the lifestyle intervention arm will receive an intervention program that consists of individual weight loss, diet and physical activity goals, incorporated into a 2 year standardized, structured telephone and mail-based intervention. In addition to diet and physical activity, the intervention will address behavioural and motivational issues relating to weight management including maintaining motivation, overcoming obstacles to success, relapse prevention, emotional distress, stress and time management.
Mail-based
Participants will receive a standardized mail-based intervention focussing on healthy living. This will include mailings at study entry as well as a two year subscription to health magazine.
Los Angeles Biomedical (LABIOMED) Research Institue at Harbor-UCLA Medical Center, Torrance
Fred Hutchinson Cancer Research Center, Seattle
Dana-Farber Cancer Institute, Boston
Beth Israel Deaconess Medical Centre, Boston
Bcca - Csi, Kelowna
Cambridge Memorial Hospital, Cambridge
Juravinski Cancer Centre, Hamilton
Grand River Regional Cancer Centere, Kitchener
London Regional Cancer Centre, London
Ottawa Hospital Regional Cancer Centre, Ottawa
Algoma District Cancer Program, Sault Ste. Marie
Scarborough Hospital, Scarborough Village
Niagara Health System, St. Catharines
Thunder Bay Regional Health Science Centre, Thunder Bay
Sunnybrook Odette Cancer Centre, Toronto
St. Michael's Hospital, Toronto
Mount Sinai Hospital, Toronto
Trillium Healthcare Centre, Toronto
Windsor Regional Cancer Centre, Windsor
Hopital Charles LeMoyne, Greenfield Park
CHUM - Hotel Dieu de Montreal, Montreal
Collaborators (1)
Novartis Pharmaceuticals
INDUSTRY
Ontario Clinical Oncology Group (OCOG)
OTHER